To add or not to add LH: Comments on recent commentaries

Reproductive BioMedicine Online

Volumn 12, Issue 4, 2006, Pages 415-417

  Lisi, Franco ^a  

^a Servizio di Fisiopatologia della Riproduzione   (Italy)

Author keywords

Follicular stimulation; IVF; Recombinant gonadotrophins; Recombinant LH

Indexed keywords

GONADORELIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

ANEUPLOIDY; CORPUS LUTEUM; CRYOPRESERVATION; FEMALE; FERTILIZATION IN VITRO; FETUS WASTAGE; HIGH RISK PATIENT; HORMONE ACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INCIDENCE; MENSTRUAL CYCLE; MULTIPLE PREGNANCY; NEGATIVE FEEDBACK; NOTE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; POSITIVE FEEDBACK; PULSATILE HORMONE RELEASE; RISK ASSESSMENT; RISK REDUCTION;

EID: 33645788336     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)61992-X     Document Type: Note

References (17)

1. Bjercke S, Fedorcsak P, Abyholm T et al. 2005 IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression. Human Reproduction 20, 2441-2447.
2. Hugues JN, Soussis J, Calderon I et al. 2005 Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study. Human Reproduction 20, 629-635.
3. Hull ML, Livesey JH, Evans JJ, Benny PS 1998 The effect of recombinant follicle stimulating hormone (Gonal-F) on endogenous luteinizing hormone secretion in women. Human Reproduction 13, 1139-1143.
4. Humaidan P 2006 To add or not to add LH: comments on a recent commentary. Reproductive BioMedicine Online 12, 284-285.
5. Kol S 2005 To add or not add LH: consideration of LH concentration changes in individual patients. Reproductive BioMedicine Online 11, 664-666.
6. Lisi F, Rinaidi L, Fishel S et al. 2005 Evaluation of two doses of recombinant luteinizing hormone supplementation in an unselected group of women undergoing follicular stimulation for in vitro fertilization. Fertility and Sterility 83, 309-315.
7. Lisi F, Rinaldi L, Fishel S et al. 2003 Use of recombinant follicle-stimulating hormone (Gonal F) and recombinant luteinizing hormone (Luveris) for multiple follicular stimulation in patients with a suboptimal response to in vitro fertilization. Fertility and Sterility 79, 1037-1038.
8. Lisi F, Rinaldi L, Fishel S et al. 2002 Use of recombinant LH in a group of unselected IVF patients. Reproductive BioMedicine Online 5, 104-108.
9. Lisi F, Rinaldi L, Fishel S et al. 2001 Use of recombinant FSH and recombinant LH in multiple follicular stimulation for IVF: a preliminary study. Reproductive BioMedicine Online 3, 188-192.
10. Loumaye E 2002 Stimulation ovarienne: Ia LH exogene est-elle necessaire chez toutes les patientes? [Ovarian stimulation: is exogenous LH necessary in all patients?] Gynecologie, Obstetrique and Fertilite 30, 890-895.
11. Manna C, Rahman A, Sbracia M et al. 2005 Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction. Gynecological Endocrinology 20, 188-194.
12. Marrs R, Meldrum D, Muasher S et al. 2004 Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reproductive BioMedicine Online 8, 175-182.
13. Messinis IE, Templeton AA 1990 Superovulation induction in women suppresses luteinizing hormone secretion at the pituitary level. Clinical Endocrinology 32, 107-114.
14. Peñarrubia J, Fábregues F, Creus M et al. 2003. LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH. Human Reproduction 18, 2689-2697.
15. Shoham Z 2002 The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertility and Sterility 77, 1170-1177.
16. Westergaard LG, Erb K, Laursen SB et al. 2001 Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study. Fertility and Sterility 76, 543-549.
17. Yarali H, Zeyneloglu HB 2004 Gonadotrophin treatment in patients with polycystic ovary syndrome. Reproductive BioMedicine Online 8, 528-537.